UNITED STATES SECURITIES

AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

 

FORM 6-K

 

REPORT OF FOREIGN PRIVATE ISSUER

PURSUANT TO RULE 13a-16 OR 15d-16

UNDER THE SECURITIES EXCHANGE ACT OF 1934

 

For the Month of May 2022

 

Commission File Number: 001-39131

 

LIMINAL BIOSCIENCES INC.

(Translation of registrant’s name into English)

 

 

440 Armand-Frappier Boulevard, Suite 300

Laval, Québec

H7V 4B4

(Address of principal executive office)

 

 

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F:

Form 20-F Form 40-F

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1):

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7):

 

 

 

 

 


INCORPORATION BY REFERENCE

 

This Report on Form 6-K (the “Report”) and Exhibit 99.1 to this Report are hereby expressly incorporated by reference into the registrant’s registration statements on Form F-3 (File nos. 333-251065, 333-251055 and 333-245703) filed with the Securities and Exchange Commission on December 2, 2020, December 1, 2020 and December 1, 2020, respectively, and the registration statement on Form S-8 (File no. 333-235692) filed with the Securities and Exchange Commission on December 23, 2019.

 

 

 

EXHIBIT LIST

 

Exhibit

 

Description

99.1

 

Notice of Annual Meeting of Shareholders and Management Information Circular dated April 13, 2022

99.2

 

Notice of 2022 Annual Meeting of Shareholders

99.3

 

Notice of Availability of Proxy Materials for the Annual General Meeting of Shareholders of Liminal BioSciences Inc.

99.4

 

Proxy Form

99.5

 

Virtual AGM User Guide

 

 

 

 


SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Liminal BioSciences Inc.

 

 

 

 

Date: May 3, 2022

 

 

 

By:

 

/s/ Bruce Pritchard

 

 

 

 

 

 

Name

 

Bruce Pritchard

 

 

 

 

 

 

Title

 

Chief Executive Officer

 

 

 

 

 


Liminal BioSciences (NASDAQ:LMNL)
Historical Stock Chart
Von Feb 2024 bis Mär 2024 Click Here for more Liminal BioSciences Charts.
Liminal BioSciences (NASDAQ:LMNL)
Historical Stock Chart
Von Mär 2023 bis Mär 2024 Click Here for more Liminal BioSciences Charts.